Financhill
Back

Sarepta Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Sarepta Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 94.24 Sell
20-day SMA: 101.11 Sell
50-day SMA: 110.69 Sell
200-day SMA: 125.58 Sell
8-day EMA: 91.61 Sell
20-day EMA: 99.38 Sell
50-day EMA: 107.77 Sell
200-day EMA: 119.29 Sell

Sarepta Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.65 Sell
Relative Strength Index (14 RSI): 30.31 Sell
Chaikin Money Flow: 3301090 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.25 - 111.51) Sell
Bollinger Bands (100): (105.8 - 127.52) Sell

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Sarepta Therapeutics Stock

Is Sarepta Therapeutics Stock a Buy?

SRPT Technical Analysis vs Fundamental Analysis

Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy or a Sell?

Sarepta Therapeutics Stock Info

Market Cap:
7.8B
Price in USD:
79.97
Share Volume:
5M

Sarepta Therapeutics 52-Week Range

52-Week High:
173.25
52-Week Low:
73.06
Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Sarepta Therapeutics Share Price Forecast

Is Sarepta Therapeutics Stock a Buy?

Fundamental Analysis of Sarepta Therapeutics

Is Sarepta Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.

Technical Analysis of Sarepta Therapeutics

Should I short Sarepta Therapeutics stock?

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.